Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000997798 | SCV000240476 | likely benign | not provided | 2020-08-05 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22873564, 19628475) |
Labcorp Genetics |
RCV000464341 | SCV000553240 | likely benign | Autosomal dominant nocturnal frontal lobe epilepsy | 2024-11-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312735 | SCV000847139 | likely benign | Inborn genetic diseases | 2018-07-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000997798 | SCV001153512 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | CHRNA4: BP4, BS2 |
ARUP Laboratories, |
RCV000997798 | SCV001471726 | uncertain significance | not provided | 2020-03-03 | criteria provided, single submitter | clinical testing |